- Home
- PHM vs DXCM Comparison
PHM vs DXCM Comparison
Compare PHM & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$118.58
HOLD
Current Price
$66.56
Company Overview
Basic Information| Metric | PHM | DXCM |
|---|---|---|
| Founded | 1950 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | PHM | DXCM |
|---|---|---|
| Price | $118.58 | $66.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $134.31 | $86.86 |
| AVG Volume (30 Days) | 1.8M | ★ 4.4M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | ★ 13.01 | 1.80 |
| Revenue | ★ $17,622,999,000.00 | $4,515,900,000.00 |
| Revenue This Year | N/A | $17.38 |
| Revenue Next Year | N/A | $12.76 |
| P/E Ratio | ★ $9.01 | $36.94 |
| Revenue Growth | 1.76 | ★ 14.21 |
| 52 Week Low | $88.07 | $54.11 |
| 52 Week High | $142.11 | $93.25 |
Technical Indicators
Market Signals| Indicator | PHM | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 54.97 |
| Support Level | $116.34 | $66.00 |
| Resistance Level | $119.90 | $68.18 |
| Average True Range (ATR) | 2.58 | 1.46 |
| MACD | -0.61 | -0.10 |
| Stochastic Oscillator | 19.81 | 36.98 |
Price Performance
Historical Comparison PHM
DXCM
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.